tiprankstipranks
Trending News
More News >
US Stem Cell Inc (DE:BHV)
BERLIN:BHV
Germany Market

US Stem Cell (BHV) Financial Statements

Compare
0 Followers

US Stem Cell Financial Overview

US Stem Cell's market cap is currently $56.58K. The company's EPS TTM is €; its P/E ratio is ―; US Stem Cell is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 82.05K$ 200.75K$ 277.09K$ 3.07M$ 6.70M
Gross Profit$ 58.28K$ 148.72K$ 212.97K$ 1.74M$ 4.59M
Operating Income$ -1.72M$ -2.14M$ -2.40M$ -3.42M$ -1.10M
EBITDA$ -2.17M$ -2.29M$ -2.40M$ -2.51M$ -508.49K
Net Income$ -2.86M$ -4.29M$ -3.38M$ -5.04M$ -2.16M
Balance Sheet
Cash & Short-Term Investments$ 5.13K$ 39.39K$ 18.57K$ 0.00$ 1.36M
Total Assets$ 68.04K$ 51.00K$ 88.15K$ 89.84K$ 1.82M
Total Debt$ 8.95M$ 8.02M$ 7.48M$ 6.18M$ 5.05M
Net Debt$ 8.94M$ 7.98M$ 7.47M$ 6.18M$ 3.69M
Total Liabilities$ 14.81M$ 12.82M$ 11.67M$ 9.57M$ 8.70M
Stockholders' Equity$ -14.75M$ -12.77M$ -11.58M$ -9.48M$ -6.88M
Cash Flow
Free Cash Flow$ -304.85K$ -1.06M$ -478.89K$ -1.38M$ 602.47K
Operating Cash Flow$ -304.85K$ -1.06M$ -478.89K$ -1.21M$ 602.47K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 166.83K$ 311.70K
Financing Cash Flow$ 270.59K$ 1.08M$ 497.46K$ -312.99K$ -543.82K
Currency in USD

US Stem Cell Earnings and Revenue History

US Stem Cell Debt to Assets

US Stem Cell Cash Flow

US Stem Cell Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis